Company
Neuron23
We’re on a Mission to Change the Future of Parkinson’s Disease
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Combining cutting-edge data science, human genetics, a potentially best-in-class therapy, and an innovative patient-centered clinical approach, we are developing a precision medicine approach designed to improve the lives of people with Parkinson's disease.
Funding snapshot
- Total raised
- $310MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series D+, $96.5M2025-06-25
Funding rounds
- Series D+
- $96.5M2025-06-25, Announced
- Series C
- $100M2022-04-04, Announced
- Series A
- $33.5M2020-12-16, Announced
- Series B
- $80M2020-12-16, Announced
Products
- Web
- NEU-111
- Web
- NEU-411
Loading relationship preview